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The sequence within the 59 untranslated region of the retroviral genome contains important cis elements for many steps
in viral replication. There is limited information available on the role of this region in foamy virus replication. Similar to other
retroviruses, the 59 untranslated region of foamy viruses predicts extensive RNA secondary structure. Serial mutations that
could change parts of the predicted secondary structure were introduced in the 59 leader sequence including the R-U5 region
of simian foamy virus type 1 (SFV-1) to investigate their role in virus genome packaging and virus replication. Point mutations
in the R-U5 regions at nucleotide positions 7–12 (I), 241–243 (B), and 256–257 (D) had no effect on virus replication. Base
substitution mutation at positions 193–195 (C), however, severely impaired virus replication. Deletion of sequences in the
leader region, between the primer-binding site and the gag gene, at positions 364–399 (d1), 397–435 (d2), or 364–435 (d3),
which included sequences for RNA genome dimerization, also blocked SFV-1 replication. Interestingly, none of these
mutations affected genome packaging or the synthesis of viral transcripts, suggesting that a step(s) of virus replication
following packaging is affected. The region between the primer-binding site and the gag gene, therefore, is not essential for
foamy virus genome packaging. Furthermore, the cis-acting elements for genome dimerization and packaging appear to be
localized in separate regions for foamy viruses. © 2000 Academic Press
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Foamy viruses are a unique group of viruses that
belong to a genus of retroviruses. These viruses can
infect a variety of cell types from different species and
induce extensive cytopathology in cell culture (Hooks
and Detrick-Hooks, 1981; Mergia et al., 1996). However,
foamy viruses do not cause disease in naturally or ex-
perimentally infected animals (Hooks and Detrick-Hooks,
1981). For these reasons, it is suggested that foamy
viruses would be ideal viral vectors for gene therapy.
This notion has recently enhanced foamy virus research
and as a result surprising features of foamy virus repli-
cation have been uncovered. Foamy virus replication
appears to be regulated by mechanisms that involve
differential gene expression. A promoter located at the 39
end of env controls the expression of the early tran-
scripts (regulatory genes) and the LTR regulates the
expression of the late transcripts (structural genes)
(Campbell et al., 1994; Lochelt et al., 1994; Mergia, 1994).
The pro-pol gene product, in which the predicted amino
acid sequence is in a different frame from that of gag, is
translated from a subgenomic message and lacks the
Gag domain (Bodem et al., 1996; Yu et al., 1996a). The
mount of this subgenomic message is very low and can
e detected only by polymerase chain reaction (PCR)
Bodem et al., 1996; Mergia et al., 1991; Muranyi and
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203lugel, 1991; Yu et al., 1996a). Translation for pro-pol
roducts commences at an initiator ATG codon located
t the 59 end of the pro gene (Enssle et al., 1996; Lochelt
nd Flugel, 1996; Mergia et al., 1991; Muranyi and Flugel,
991). Retroviruses have Cys-His motifs in the nucleo-
apsid domain of the Gag protein necessary for nucleic
cid binding (reviewed in Berkowitz et al., 1996; Linial
nd Miller, 1990). Interestingly, foamy viruses lack this
otif, which is present in all other retroviruses (Flugel et
l., 1987; Herchenroder et al., 1994; Kupiec et al., 1991;
ergia and Luciw, 1991; Renne et al., 1992). In the cor-
esponding region, foamy viruses contain three Gly-Arg-
ich sequences, and one of these has been shown to be
equired for nucleic acid binding and virus replication (Yu
t al., 1996b). Inspection of the genome of foamy virus
articles reveals large amounts of double-stranded DNA
nd it is estimated that one of five virus particles con-
ains the DNA genome (Yu et al., 1996a). Recently, evi-
ence was established demonstrating that DNA isolated
rom the virus particle is infectious, suggesting that
oamy viruses have a distinct replication pathway (Yu et
l., 1999).
The sequence within the 59 untranslated leader region
f retroviral RNA contains important cis elements for
any steps in viral replication. This region is complex,
ith specific sequences that have features of secondary
tructures. Sequences throughout the 59 untranslated
egion have been implicated in viral RNA encapsidation,
iploid genome dimerization, and efficient gag transla-
ion (Berkowitz et al., 1996; Linial and Miller, 1990; Miele
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204 PARK AND MERGIAet al., 1996). Similar to other retroviruses, the 59 untrans-
ated region of foamy viruses predicts an extensive RNA
econdary structure (Fig. 1). The R-U5 and leader region
etween the primer-binding sites and the gag gene are
ighly conserved in all primate foamy viruses character-
zed thus far (Herchenroder et al., 1994; Mergia and
uciw, 1991). A palindromic sequence (UCCCUAGGGA)
resent in the leader region of all the primate foamy
iruses is reported to be important for the dimerization of
he diploid genome of human foamy virus (HFV) (Erlwein
t al., 1997). The splice donor site involved in generating
ubgenomic messages is located 51 bases downstream
rom the transcription initiation site within R, indicating
hat the sequence between the splice donor site and the
tart of the gag gene is important in genome packaging
Muranyi and Flugel, 1991). Recent studies on foamy
irus vector construction suggest that the 59 untranslated
region is critical for gene transduction, similar to other
retroviruses (Wu et al., 1998). Additional sequences re-
uired for transfer of foamy virus vector are found in the
9 region of the pol gene (Erlwein et al., 1998; Heinkelein
t al., 1998; Wu et al., 1998). Whether these cis-acting
lements are required for foamy virus genome encapsi-
ation remains to be determined. In order to gain in-
ights into mechanisms of foamy virus genome packag-
ng and replication, we have introduced mutations in the
utative secondary structure of the 59 untranslated re-
ion of simian foamy virus type 1 (SFV-1) and analyzed
he effects on viral transcripts, packaging, and virus
roduction.
RESULTS
loning of an indicator cell line for titration of SFV-1
Yu and Linial (1993) developed a novel sensitive
ethod for quantifying HFV based on the notion that the
oamy virus transactivator is necessary for virus replica-
ion and gene expression directed by the viral LTR pro-
oter. They established a cell line (FAB) containing a Lac
gene under the control of the HFV LTR. This cell line
xpresses b-galactosidase (b-Gal) only in the presence
f the HFV tas gene. When FAB cells are infected with
FV, they express b-Gal as a result of virus-mediated
as production and subsequent activation of the pro-
oter controlling the indicator gene. Thus, the number of
lue cells can reflect viral titer. Since the SFV-1 tas gene
oes not transactivate gene expression directed by the
FV LTR (Mergia et al., 1992), it is necessary to develop
similar indicator cell line for titering SFV-1. The plasmid
onstruct (pU3b-gal/zeo) containing the SFV-1 LTR pro-
moter expressing the LacZ gene and zeocin-resistant
gene for selection under the control of SV-40 promoter
was transfected into L-929, COS-7, and CRFK cell lines.
Cells that survived zeocin selections were further pro-
cessed for the presence of the LacZ gene by PCR and for
b-Gal expression by infection with SFV-1. All mock-in-fected COS-7 and CRFK clones showed a high back-
ground with low-level-intensity blue cells. Mock-infected
L-929 clones showed no background of b-Gal activity. Of
12 L-929 cell clones tested, 1 (LBZ4) expressed b-Gal as
bserved by intense blue color following SFV-1 infection.
he LBZ4 cell line was selected to titer SFV-1.
eplication analysis of SFV-1 mutants
To establish a basis for understanding the mecha-
isms of genome packaging and replication of SFV-1, we
ntroduced mutations in the R-U5 regions of the LTR and
n the leader region between the primer-binding site
PBS) and the start of the gag gene. The sequence of
-U5 plus the leader region between the PBS and the
tart of the gag gene predicts a stable, complex RNA
econdary structure (Fig. 1). Point mutations were intro-
uced in the R-U5 region that could change parts of the
tructure as shown in Fig. 1. Small deletions were cre-
ted in the region between the PBS and the gag gene. To
etermine the effect of these mutations on virus replica-
ions, wild-type or mutant SFV-1 proviral DNA was trans-
ected into 293 cells. The cultures were maintained for 12
ays and monitored every 2 days for virus replication by
easuring virus-associated reverse transcriptase (RT)
ctivity from the supernatants and observing cytopathic
ffect under a light microscope. Mutants I, B, and D,
hich had base substitutions at positions 7–12, 242–243,
nd 256–257, respectively, showed levels of virus pro-
uction similar to that of the wild type, with RT values
eaching a peak at 8 to 10 days posttransfection (Fig. 2A).
ransfected cells were observed for up to 12 days for the
ppearance of cytopathic effect. Cells showed typical
ytopathology of foamy virus infection as described pre-
iously (Mergia et al., 1996). The extent of cytopathology
nd the rate at which it occurred among cells transfected
ith mutants I, B, or D initially varied but reached levels
imilar to those for the wild type at 8 to 10 days, corre-
ponding to peak RT values (Fig. 2C). Interestingly, su-
ernatants obtained from cells transfected with either a
ase substitution mutant at positions 193–195 (C) or
hree deletion mutants at positions 364–399 (d1), 397–
35 (d2), and 364–435 (d3) had no RT activity. Further-
ore, no cytopathology was observed in the 12 days
osttransfection with these mutants, indicating that virus
eplication was impaired.
Virus titer from either wild-type or mutant transfected
ells was determined by infecting the indicator LBZ4
ells. Culture supernatants of 293 cells harvested 4 days
fter transfection were used to quantify SFV-1 by infect-
ng LBZ4 cells and counting b-Gal-positive cells. Cells
nfected with I, B, or D mutants had numbers of b-Gal-
positive cells equivalent to those for wild-type virus-
infected cells, confirming the RT and the cytopathic re-
sults. No blue cells were observed when LBZ4 cells
m
p
s
R
n
a
sks. d1,
20559 LEADER SEQUENCE OF SFV-1were infected with supernatant harvested from C, d1, d2,
or d3 transfected cells. The replicative properties of the
mutant viruses were also assessed following cell-free
infection. LBZ4 cells were infected with a multiplicity of
infection of 0.05 of each mutant. Since no virus produc-
tion was observed from cells transfected with mutants C,
d1, d2, or d3, the total supernatant volumes collected
were used to infect 293 cells. Culture medium was col-
lected for 10 days at 2-day intervals and titers were
determined by infecting the indicator cells. The mutants
FIG. 1. (A) Schematic representation of SFV-1 provirus. (B) The pred
primer-binding site and the gag gene of SFV-1. The secondary st
www.ibc.wustl.edu/;zucker/rna/foldml.cgi). The secondary model show
by the Mfold program. The calculated free energy is 2110.2 kcal. The reg
Point mutations were introduced at both the 59 and the 39 R-U5 regions
the mutations are shown. Mutated nucleotides are indicated with asteri
regions.I, B, and D showed titers similar to that for the wild type,
except that mutant I had a log higher virus production at
m
pdays 8 through 10 after infection (Fig. 2B). Although all
collected supernatant from mutant C and the deletion
mutants was used to infect 293 cells, none of the indi-
cator cells were positive for b-Gal, indicating that these
utants failed to yield infectious virus particles. The
atterns of replication in the infection and transfection
ystems are consistent and show that mutations in the
-U5 region at positions 7–12, 241–243, and 256–257 had
o effect on virus replication. The site-specific mutations
t positions 193–195 in the U5 region and the deletion
NA secondary structure of the R-U5 and leader region between the
of SFV-1 RNA was generated by Zucker’s Mfold program (http://
has the lowest free energy among 16 proposed structures predicted
f the predicted stem-loops used to introduce point mutations are boxed.
provirus. The predicted structures before and after the introduction of
d2, and d3 represent deletion mutants and the arrows indicate deletedicted R
ructure
n here
ions o
of theutations between the PBS and the start of the gag
roduced severe replication defects.
ollows:
DNA t
206 PARK AND MERGIAViral RNA synthesis
To determine whether viral RNA synthesis was af-
fected in cells transfected with the mutants C, d1, d2, or
d3, total RNA was extracted from 293 cells transfected
with wild-type or mutant provirus DNA and analyzed on
Northern blots by hybridization with the tas-orf2 region
located between env and the LTR. As shown in Fig. 3, the
probe hybridized to all foamy virus transcripts that were
previously identified as the mRNAs of the full-length
transcripts and the subgenomic env and tas-orf2 (Mergia
et al., 1991). All mutants including those that did not yield
infectious virus particles (C, d1, d2, and d3) showed the
same pattern of viral transcripts. Furthermore, all of the
FIG. 2. Replication and cytopathic effect of wild-type or mutant SFV
transcriptase analysis of supernatants from cell cultures transfected wi
was assayed under conditions optimized for foamy virus with Mn21 cati
per minute. Samples were harvested at the indicated time intervals in
replicate samples was observed. (B) Titer of cell-free wild-type or muta
determine the properties of virus replication. Virus was collected at diffe
b-Gal-positive cells. The levels of cytopathic effect induced by the wild
in (C) and (D), respectively. Levels of cytopathology were scored as f
70–100% cytopathic effect. The numbers at the top indicate days aftermutants and the wild type synthesized similar levels of
RNA, indicating that the mutations had no effect on virusRNA transcription at 2 days posttransfection. Analysis of
RNA at 5 days posttransfection of the wild-type and
mutants I, B, and D showed similar RNA band patterns,
with increased amounts of transcripts that encode the
structural genes (Fig. 4A). None of the transcripts that
encode the structural genes were detected by Northern
analysis at 5 days posttransfection with RNA isolated
from cells transfected with mutant C or the deletion
mutants. These transcripts, however, were detected in
these samples by reverse transcriptase-polymerase
chain reaction (RT-PCR) (Fig. 4C). In RNA samples iso-
lated from cells transfected with these mutants, less
abundant 2.8-kb transcripts that represented the tas-orf2
s in transfected (A and C) and infected (B and D) cells. (A) Reverse
type or mutant pSFV-1 at different time intervals. Reverse transcriptase
nzair et al., 1982). The reverse transcriptase activity is shown in counts
te and assayed for reverse transcriptase. Less than 10% variation in
1. Supernatants from transfected cells were harvested and infected to
e intervals and titered using the indicator LBZ4 cell line and counting
r the mutants SFV-1 in the transfected and infected cells are indicated
1, 5–10%; 11, 10–30%; 111, 30–50%; 1111, 50–70%; 11111,
ransfection or virus infection.-1 viru
th wild-
ons (Be
triplica
nt SFV-
rent tim
-type omessages were present at 5 days posttransfection.
Taken together these results indicated that none of the
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20759 LEADER SEQUENCE OF SFV-1mutations introduced affected viral RNA synthesis. With
the deletion mutants and mutant C, however, virus rep-
lication was impaired after RNA synthesis and as a result
the next round of virus replication was blocked. As the
number of nontransfected cells increased, the amount of
total viral RNA recovered was diluted out at 5 days
posttransfection, thereby limiting the detection of the
transcripts that encode structural proteins, which were
already less abundant to begin with at 2 days posttrans-
fection. A faint band of the tas-orf2 messages repre-
sented viral RNA only from transfected cells, which was
abundant at 2 days posttransfection.
FIG. 3. Northern analysis of SFV-1 transcripts from 293 cells har-
vested 2 days after transfection. Cells were transfected with wild-type
(Wt) or mutant (I, B, C, D, d1, d2, or d3) SFV-1 provirus. M represents
RNA isolated from mock transfected cells. Probe from the tas-orf2
region of SFV-1 was used to identify viral messages.
FIG. 4. (A) Northern blot analysis of SFV-1 RNA from cells harveste
RT-PCR of SFV-1 RNA isolated 5 days after transfection. A primer (c) at th
of R (a) and the 39 end of U5 (b) were used to amplify the cDNA. The p
harvested at 5 days from cells transfected with wild-type (Wt) or mutant C, d1
RT-PCR in the presence of reverse transcriptase and 2RT in the absence ofAnalysis of virus particle-associated genome
To determine whether the viral genome produced from
cells transfected with mutant provirus was encapsidated
into virions, dot blot hybridization was performed with
nucleic acid isolated from virus particles. Culture me-
dium was harvested at day 2 or 5 posttransfection to
isolate virions. Viral nucleic acids were blotted onto a
nylon membrane and hybridized to a gag-specific 32P-
abeled probe. As shown in Fig. 5A, at 2 days posttrans-
ection, all mutants were positive for viral nucleic acid
ith the gag-specific probe, indicating packaging of the
iral genome. The particle-associated nucleic acid was
lso detected by RNase protection assay from the cul-
ure supernatant of all mutants including C, d1, d2, and
3 (Fig. 6). RNAs from virus particles C, d1, d2, and d3
evealed similar levels of the expected protected frag-
ents of 365, 271, 235, and 235 nucleotides, respectively,
hen hybridization was done with the 443-nucleotide
iboprobe synthesized with pSPE-X vector. At 5 days
osttransfection, the gag probe also hybridized to nu-
leic acid isolated from viral particles harvested from
ells transfected with wild type or mutants I, B, or D (Fig.
C). However, no gag-specific nucleic acid was observed
rom supernatant harvested at 5 days posttransfection from
ells transfected with mutant C or the deletion mutants.
hese results corroborated the finding that these mutations
mpaired virus replication. The fact that gag-specific nucleic
cid was observed in the virion at 2 days posttransfection
ut not at 5 days by dot blots indicates that packaging of the
iral genome was not affected; rather a subsequent step(s)
f SFV-1 replication was impaired, limiting the detection of
he packaged genome at day 5.
s after transfection. (B) Schematic representation of primers used for
d of the pol gene was used to generate cDNA. Primers at the beginning
and size of the PCR product are indicated. (C) RT-PCR of cellular RNAd 5 day
e 59 en
osition, d2, or d3. M is RT-PCR from mock transfected cells. 1RT represents
the enzyme.
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208 PARK AND MERGIADISCUSSION
The 59 untranslated region of foamy virus forms an
xtensive stable RNA secondary structure. There is only
imited information available on the function of this re-
ion in foamy virus replication. To determine the role of
his structure in foamy virus replication, we have intro-
uced a series of mutations in the leader region includ-
ng the R-U5 that potentially affect parts of the secondary
tructure. Among several base substitution mutations we
reated in the R-U5 region, alteration of the sequence at
ositions 193–195 of U5 severely impaired virus replica-
ion. Deletion of the sequences in the leader region at
ositions 364–399 and 397–435 also blocked SFV-1 rep-
ication. Although virus replication was impaired, these
utants synthesized both spliced and unspliced mes-
FIG. 5. Dot blot analysis of SFV-1 nucleic acids from virions isolated
(A) and 5 (C) days after transfection. Nucleic acids isolated from
ell-free virus particles were subjected to dot blot analysis with gag-
pecific probe. Each sample represents nucleic acid from virions iso-
ated from an equivalent amount of culture supernatants. Signals of
iral nucleic acids were quantified by image analysis using Image
tore 7500 (Ultra Violet Product Ltd., San Gabriel, CA) and are ex-
ressed as a percentage relative to the wild-type value (B and D). Titer
f virus particles was expressed as a percentage of the wild-type titer.ages at levels similar to the wild type. Cell-free virions
harvested at 2 days posttransfection) of these mutantsontained viral nucleic acid as determined with gag-
pecific probe, indicating packaging of the viral genome.
herefore, these mutations affected steps of virus repli-
ation following packaging.
Sequences at the 39 end of the pol gene and the 59
ntranslated region are critical for foamy virus vector
onstruction (Erlwein et al., 1998; Heinkelein et al., 1998;
u et al., 1998). However, the precise cis-acting ele-
ent(s) for encapsidation of the viral genome is not
efined. For other retroviruses, the leader region located
etween the primer-binding sites and the start of the gag
ene is critical for packaging of the genome (Berkowitz
FIG. 6. Analysis of RNA content of virions of wild-type or mutant
SFV-1 by RNase protection experiments. (A) The 59 end of the SFV-1
provirus that includes the LTR, the leader region, and the 59 end of the
gag gene with relevant restriction sites is shown. The probe used for
protection is indicated by an arrow below the genome representation.
(B) The products of protected RNAs were analyzed in 7 M urea–8%
polyacrylamide gel. The first lane represents molecular markers in
nucleotides. Lanes 2–10 are RNase-resistant products remaining after
hybridization of the riboprobe to RNA isolated from virions of the
wild-type (wt), mutant (I, B, C, D, d1, d2, or d3), or mock transfected cells
(M). Lanes 11 and 12 represent RNase treated and untreated riboprobe,
respectively.
20959 LEADER SEQUENCE OF SFV-1et al., 1996; Linial and Miller, 1990). In HIV-1, there are two
clearly defined packaging elements within the leader
region. Deletions in the untranslated region of HIV be-
tween the major splice donor and the gag initiation
codon identified a major cis-acting packaging signal
sequence (Aldovini and Young, 1990; Clavel and Oren-
stein, 1990; Lever et al., 1989). For efficient encapsidation
of the HIV-1 genome, sequences upstream of the splice
donor site are also required (Kim and O’Rear, 1994; Pail-
lart et al., 1996). Our results showed that deletion of
SFV-1 sequences in the corresponding region had no
effect on packaging; it had only a minor role, if any. In
HIV-2 the packaging signal is also located in the leader
region (McCann and Lever, 1997). However, in contrast to
HIV-1, the sequence between the splice donor site and
gag plays a lessor role in genome encapsidation and the
major cis-acting packaging element is found to be im-
mediately upstream of the 59 splice donor site (McCann
and Lever, 1997). Similarly, the encapsidation site for
avian leukosis virus (ALV) lies upstream of the splice
donor site (Katz et al., 1986; Sorge et al., 1983). The splice
donor site for foamy virus is within R of the LTR and is
located 51 bases downstream from the transcription ini-
tiation site (Muranyi and Flugel, 1991). We altered one of
the stem structures in the R region upstream of the splice
donor site (mutant I) by base substitutions, but this had
no effect on virus replication and genome packaging.
The sequence between the splice donor site and the gag
start codon is considerably long compared to other ret-
roviruses and may contain important cis-acting elements
that are critical for virus replication. However, site-spe-
cific mutations introduced in the region between the
splice donor and the primer-binding site also had no
effect on genome packaging. The packaging signal for
SFV-1 may lie in the R-U5 region where no mutations
were introduced. Alternatively, since foamy viruses have
a distinct replication pathway, our results may reflect the
complexity and uniqueness of foamy virus genome en-
capsidation. Furthermore, it remains to be determined
whether the sequences at the 39 end of the pol gene are
involved in foamy virus genome packaging.
Dimerization is postulated to act as a positive signal
for encapsidation of two genomic RNA molecules (Bieth
et al., 1990; Darlix et al., 1990; Katoh et al., 1993; Prats et
al., 1990). This process is also linked to reverse tran-
scription and gag translation (Bieth et al., 1990; Panga-
niban and Fiore, 1988). For HFV RNA genome dimeriza-
tion, three sites, including one that includes a palin-
dromic sequence, are identified in the leader region
between the primer-binding site and the gag gene
(Erlwein et al., 1997). This region has also been identi-
fied to be critical for foamy virus vector construction (Wu
et al., 1998). The mutant d1 that we created has a 36-
nucleotide deletion including the palindromic sequence.
Mutant d2 has a deletion of 39 nucleotides immediately
following the palindromic sequence and before the be-ginning of the gag initiation codon. The fact that our
results showed genome encapsidation with these mu-
tants indicates packaging of the foamy virus genome
without the prerequisite of dimerization. Similarly, muta-
tions that prevent in vitro dimerization impaired infectivity
despite normal virion RNA content in HIV-1, indicating
that RNA dimerization is not necessary for genome pack-
aging (Clever and Parslow, 1997; Tchenio and Heidmann,
1995). For foamy viruses, therefore, the cis-elements for
dimerization and packaging may be localized in separate
regions of the SFV-1 genome. Furthermore, packaging of
the genome with mutant C and the deletions indicate that
viral protein synthesis is not impaired by these muta-
tions.
The mutations in C could introduce defects in several
steps of reverse transcription such as the initiation com-
plex and strand jump. To establish a stable initiation
complex for reverse transcription in avian retroviruses,
two secondary structures in the middle of U5 and in the
leader region flanking the primer-binding site are re-
quired (Aiyar et al., 1994; Cobrinik et al., 1991; Miller et al.,
1997). A deletion in the 39 part of U5 did not block
packaging but affected reverse transcription in murine
leukemia virus (Murphy and Goff, 1989). The mutation
region of mutant C lies in the 59 part of U5 of SFV-1 and
this region could contribute to forming a stable initiation
complex of reverse transcription. Thus, the lack of repli-
cation could be caused by a defect at the level of reverse
transcription. It is interesting to note that we observe no
reverse transcriptase activities in supernatants har-
vested from cells transfected with mutant C or any of the
deletion mutants. The regions where these mutations
were introduced may be critical for association or enzy-
matic activity of the reverse transcriptase. After the sub-
mission of this article, Heinkeliein et al. (2000) suggested
that a similar region in the HFV genome might be re-
quired for polymerase incorporation and/or activity. Bald-
win and Linial (1998) reported that Pol is not required for
assembly of HFV core particles or packaging of the viral
genome, supporting our observation that the SFV-1 ge-
nome can be packaged even though no reverse tran-
scriptase activity was detected.
MATERIALS AND METHODS
Virus and cell cultures
Cell lines 293 (human embryonic kidney fibroblasts),
COS-7 (African green monkey fibroblasts), CRFK (Cran-
dell feline kidney fibroblasts), and L929 (murine fibro-
blasts) were obtained from the American Type Culture
Collection (Rockville, MD). Cells were grown in Dulbec-
co’s modified Eagle’s medium supplemented with 10%
fetal calf serum. SFV-1 was propagated in the 293 cell
line.
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210 PARK AND MERGIAConstruction of plasmids
All plasmids were derived from a SFV-1 infectious
proviral DNA, pSFV-1. The construction of pSFV-1 was
described previously (Mergia and Wu, 1998). Recombi-
nant DNA manipulations were performed by standard
techniques (Sambrook et al., 1989). Site-specific muta-
tions were constructed by PCR with pairs of oligonucle-
otides containing altered sequences as described pre-
viously (Ho et al., 1989). Primers used for mutations are
listed in Table 1. Base substitutions were introduced in
the R region at positions 7–12 (I) and in the U5 region at
positions 241–243 (B), 193–195 (C), and 256–257 (D) (Fig.
1). In all these mutants, the sequences were altered at
both the 59 and the 39 LTRs. Proviruses with deletion
mutations in the leader region between the PBS and the
start of the gag were created by ligating and subcloning
appropriate PCR-generated DNA fragments. Mutants d1,
d2, and d3 contained proviruses with deletions at posi-
tions 364–399, 397–435, and 364–435, respectively. All
mutations were confirmed by sequencing double-
stranded DNA templates using the Perkin–Elmer Applied
Biosystem Division (PE/ABD) 373A automated DNA se-
quencer.
DNA transfections
The proviral genome of either wild-type or mutant
SFV-1 was transfected into 293 cells by using a lipo-
some-mediated method with LipofectAMINE Reagent
(Life Technologies, Inc., Gaithersburg, MD). Briefly, cells
were seeded at a density of 3 3 105 in six-well plates and
ncubated overnight. The transfection was performed the
ext day when the cells were 70 to 80% confluent. One to
TABLE 1
Oligonucleotide Primers Used in PCR for Construction of Mutants
Primera Sequenceb Nucleotide positionsc
F1 atagatatcgtgcactgcg 400–411
R1 tgtgtcgacaattgtcgtgga 329–317
R2 cacgatatcccgacttata 365–351
R3 actgatatccctagggatta 396–384
IR agcgagttctgttgagctcccgt 19–4
IF ggagctcaacagaactcgctgcgccgag 21–27
CR cataaaggggtgaaagagac 202–183
CF tctttcacccctttatgtaaagtga 186–210
BR actagatccaccctaagca 250–231
BF ttagggatggatctagtgggataagtg 234–260
DR tacccacaaatcccactag 264–246
DF gtgggatttgtgggtactacacttat 249–274
a R, reverse primer; F, forward primer.
b Underlined sequences are modified from wild-type DNA sequence.
c Nucleotide number position 1 1 represents the beginning of the R
region of the LTR.wo micrograms of DNA was mixed with LipofectAMINE
eagent and used to transfect 293 cells. Five hours after
L
iransfection 1 ml of DMEM with 20% FBS was added to
he culture without removing the transfection mixture.
he medium was replaced with DMEM containing 10%
BS 24 h after transfection. Supernatants from trans-
ected cells were harvested every other day to monitor
irus production. A plasmid construct expressing the
acZ gene (pCV7-9) was used as a control to monitor for
ransfection efficiency (Wu and Mergia, 1999).
everse transcriptase assay
RT assays were performed as described previously
Benzair et al., 1982). Briefly, 1 ml of supernatant taken
from infected cell culture was centrifuged for 1 h at
12,000 rpm to pellet the virus. Supernatants for RT were
harvested every 2 days for 12 days. The pellet was
resuspended in 50 ml of 50 mM Tris–HCl (pH 8), NP-40
(0.1%), dithiothreitol (1 mM), KCl (40 mM), EGTA (0.5 mM),
MnCl2 (1 mM), and BSA (100 mg/ml). Virus particle-asso-
iated RT activity was assayed in triplicate with [3H]dTTP
s a precursor and poly(rA)/oligo(dT) as a template/
rimer.
stablishing a b-Gal expression cell line for titering
SFV-1
Plasmid pL1 (FFV)b-gal/zeo, a gift from Dr. Axel Reth-
wilm of Technische Universita¨t Dresden, Germany, con-
tained the LacZ gene under feline foamy virus (FFV) LTR
promoter. This plasmid also had a zeocin-resistance
gene under the control of a SV40 promoter for selection.
Plasmid pU3b-gal/zeo was constructed by replacing the
FFV promoter sequence in pL1 (FFV)b-gal/zeo with the
U3 region of the SFV-1 LTR at the unique Bgl/II to BamHI
sites. The U3 region of SFV-1 was obtained by digesting
plasmid pSFV-1LTR/CAT-41 (Mergia et al., 1991) with
BamHI. One microgram of pU3b-gal/zeo was transfected
nto COS-7, CRFK, and L929 cells in 6-well plates. Two
ays after transfection, cells were 10-fold serially diluted
nd transferred to 100-mm plates. Drug-resistant cells
ere selected by culturing cells in medium containing
00 mg/ml of zeocin (InVitrogen, Carlsbad, CA). The pres-
nce of the Lac-Z gene was confirmed by PCR using
airs of primers in the surviving cells. Stably transfected
ells were transferred to 24-well plates and tested for
b-gal expression by infecting them with SFV-1 virus
stock. A cell line (LBZ4), derived from L929 cells, which
expresses b-gal upon SFV-1 infection, was used as an
ndicator cell for further experiments.
To titer the level of virus production from cells trans-
ected with either wild-type or mutant SFV-1, the indicator
LBZ4) cells were seeded at 3 3 104 cells per well in a
4-well cell culture plate. Supernatants harvested from
ells transfected with wild-type or mutant SFV-1 proviral
NA were 10-fold serial diluted and used to infect the
BZ4 cells. Forty-eight hours after infection, in situ stain-
ng for b-Gal activity was performed by fixing cells with
gR
t
M
t
t
d
c
c
w
p
g
p
c
p
a
p
k
D
E
21159 LEADER SEQUENCE OF SFV-10.25% gluteraldehyde and staining with 0.2% 5-bromo-4-
chloro-3-indolyl-b-D-galactopyranoside. Blue-stained
positive cells were viewed under a microscope and
scored.
RNA isolation and blot hybridization
Cytoplasmic RNA was extracted from cells transfected
with either wild-type or mutant proviral DNA. Cells were
harvested from three wells of a six-well culture plate and
RNA was isolated using Tri-Zol reagent (Gibco BRL,
Frederick, MD). The RNA was treated with 10 units of
RNase-free DNase I (Ambion, Austin, TX) for 30 min at
37°C. DNase was removed by treating samples with
phenol:chloroform:isoamyl alcohol (25:24:1) twice and by
ethanol precipitation. Twenty-five micrograms of RNA
was fractionated on a 1.1% agarose gel containing 2.2 M
formaldehyde and transferred to a nylon membrane
(MagnaGraph; Micron Separations Inc., Minnetonka,
MN) for hybridization. The membrane was hybridized
under stringent conditions to a [a-32P]dATP-labeled DNA
fragment representing the tas-orf2 region located be-
tween env and the LTR.
Virion nucleic acids were prepared from supernatant
of proviral DNA transfected cells. Culture supernatants
harvested 2 or 5 days posttransfection were treated with
RNase-free DNase I. The level of virus production from
each of the transfected cells was determined by infecting
the indicator cells (LBZ4) and scoring b-Gal-positive
cells as described above. Virus particles were pelleted
by layering over an equal volume of TNE [10 mM Tris–
HCl, 150 mM NaCl, 1 mM EDTA (pH 7.5)] containing 20%
sucrose and by centrifugation at 25,000 rpm for 2 h. The
pellets were resuspended in TNE and lysed with 1% SDS
and 200 mg/ml Proteinase K (Sigma, St. Louis, MO) at
37°C for 30 min. The lysed samples were extracted with
phenol:chloroform:isoamyl alcohol and ethanol-precipi-
tated. Viral nucleic acids were dot blotted using Dot Blot
Manifold (Gibco BRL) onto a nylon membrane and hy-
bridized with a [a-32P]dATP-labeled DNA fragment of the
ag region of SFV-1.
Nase protection assay
For RNase protection analysis of the SFV-1 genome in
he virus particles, the pSP73 plasmid (Promega Biotec,
adison, WI) was used. The SFV-1 DNA fragment from
he 39 end V3 of the LTR to the 59 end of gag that includes
he first 180 nucleotides of the gag sequences was
igested with restriction enzymes EcoRI and XbaI and
loned into pSP73 to generate pSPE-X. The pSP73 clone
ontaining the SFV-1 insert was linearized by digestion
ith restriction enzyme NarI located at the S9 end of the
rimer-binding site. 32P-labeled antisense riboprobe was
enerated in in vitro transcription reactions with SP6
olymerase (Promega) (Melton et al., 1984). Virus parti-
les were prepared by transfection of mutant or wild-typerovirus. The genome was isolated from virus particles
nd was used for RNase protection with SFV-1 antisense
robe using the Direct Protect RNase Protection Assay
it as recommended by the manufacturer (Ambion).
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